We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Cutaneous Rosai‐Dorfman disease after Covid 19 vaccination treated with thalidomide.
- Authors
Grimaldi, Marta; Perino, Francesca; Moretta, Gaia; Antonelli, Flaminia; Paradisi, Andrea; Ricci, Francesca; Abeni, Damiano; Didona, Biagio; Fania, Luca
- Abstract
Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide We report here, to the best of our knowledge, the first case of cutaneous Rosai-Dorfman disease observed following vaccination against coronavirus-19 disease. Another condition that links histiocytes to COVID-19 is a macrophage hyperactivation syndrome called Hemophagocytic lymphohistiocytosis (HLH), found both post-COVID-19 infection and post-vaccination.
- Subjects
NON-langerhans-cell histiocytosis; SKIN diseases; COVID-19; ERDHEIM-Chester disease; COVID-19 vaccines; THALIDOMIDE
- Publication
Dermatologic Therapy, 2022, Vol 35, Issue 11, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.15864